Skip to main content
An official website of the United States government

Biometry

Contributes to the rigor and reproducibility of cancer research through statistical consultation and mathematical modeling. Supports research in biostatistical methods and data analytics, machine learning, and artificial intelligence for cancer risk prediction and reduction.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Resources

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Berger, Vance, Ph.D.
vance.berger@nih.gov
240-276-7142
5E628 Statistician | Biometry
Bowles, Heather, Ph.D.
heather.bowles@nih.gov
240-276-6794
5E640 Program Officer | Biometry
Cancer Prevention Fellowship Program
Dodd, Kevin, Ph.D.
kevin_dodd@nih.gov
240-276-7021
5E126 Deputy Chief | Biometry
Hu, Ping, Sc.D.
ping.hu@nih.gov
240-276-7015
5E118 Statistician | Biometry
Morris, Lawrence
lawrence.morris@nih.gov
240-276-7137
5E112 Program Specialist | Biometry
Prorok, Philip C, Ph.D. [C]
philip.prorok@nih.gov
240-276-7131
Contractor | Office of the Director
Biometry
Sirota, Lev, Ph.D. [C]
lev.sirota@nih.gov
240-276-5127
5E114 Contractor | Biometry
Uzzell, Norwood
norwood.uzzell@nih.gov
240-276-7141
5E222 Program Support Assistant | Biometry
Xu, Jian-Lun, Ph.D.
jian-lun.xu@nih.gov
240-276-7023
5E128 Statistician | Biometry

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Sen, Subrata

University Of Tx Md Anderson Can Ctr
United States

Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer 5U01CA214263-07 Matthew Young, Ph.D.
Shah, Sohrab P

Sloan-Kettering Inst Can Research
United States

Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer 5R01CA281928-03 Christos Patriotis, Ph.D., M.Sc.
Shain, Alan Hunter

University Of California, San Francisco
United States

Pre-cancer atlas of skin cancer 4U01CA294536-02 Nicholas Hodges, Ph.D.
Shalon, Tidhar Dari

Envivo Bio Inc
United States

Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring 5R33CA260665-04 Amit Kumar, Ph.D.
Shelby, Rebecca A

Duke University
United States

Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis 5R01CA249959-05 Brennan Streck, Ph.D., RN, M.P.H.
Shelby, Rebecca A

Duke University
United States

Improving outcomes for women experiencing premature or early menopause after cancer: development and pilot testing of a novel intervention 1R21CA301298-01 Goli Samimi, Ph.D., M.P.H.
Shiozawa, Yusuke

Wake Forest University Health Sciences
United States

Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy 1R21CA297068-01 Rachel Altshuler, Ph.D.
Shirwan, Haval

University Of Missouri-Columbia
United States

Developing a novel agonist of CD137 for cancer immunoprevention 5UG3CA290305-02 Altaf Mohammed, Ph.D.
Shu, Xiao-Ou

Vanderbilt University Medical Center
United States

Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer 5R01CA227133-05 Matthew Young, Ph.D.
Shureiqi, Imad

University Of Michigan At Ann Arbor
United States

ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism 5R01CA266223-04 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Siddique, Shahzad

Commonspirit Health Research Institute
United States

CIRI Oncology Research Alliance 3UG1CA189809-11S1 Vanessa A. White, M.P.H.
Sidransky, David

Johns Hopkins University
United States

Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma 5R01CA265975-04 Wendy Wang, Ph.D., M.Sc.
Sieren, Jessica C

University Of Iowa
United States

Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers 5R01CA267820-03 Nicholas Hodges, Ph.D.
Sigel, Keith Magnus

Icahn School Of Medicine At Mount Sinai
United States

The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors 4R01CA256660-05 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Simeone, Diane M

University Of California, San Diego
United States

Biomarker Validation in Pancreatic Cystic Neoplasms 5U01CA282272-03 Matthew Young, Ph.D.